Physician

Wendewessen Amde, M.D.

According to 2025 Medicare claims, Wendewessen Amde, M.D. (NPI: 1386837474) practices ophthalmology in the Elgin, IL market, with the plurality of this provider's patient population coming from De Kalb, IL. This provider's primary affiliated billing organization is DEKALB EYE CONSULTANTS, LLC (NPI: 1326380510; TIN: 237087041) and primary practice location at 60178-3103.

Amde's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,018 traditional Medicare patients, billed 10,617 HCPCS/CPT codes, and received $1,259,182 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,207 prescription claims across 332 beneficiaries totaling $58,248 in drug costs, led by Brimonidine Tartrate (Brimonidine Tartrate). Open Payments data shows 15 records totaling $381. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $536,499 to $1,259,182. Similarly, Part D prescription costs have risen steadily, from $24,171 to $58,248. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$897K$1.8M2015 Medicare payment: $536,499 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $667,049 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $681,677 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $782,027 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,168,509 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,672,125 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,733,827 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,794,123 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,613,055 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,259,182 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156106,572$536,499
20167748,724$667,049
20178029,489$681,677
20188719,871$782,027
20191,06811,044$1,168,509
20201,0077,850$1,672,125
20211,0429,051$1,733,827
20221,0269,105$1,794,123
20231,08920,710$1,613,055
20241,01810,617$1,259,182

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$37K$74K2015 Drug cost: $24,171 (USD; Tot_Drug_Cst)2016 Drug cost: $31,228 (USD; Tot_Drug_Cst)2017 Drug cost: $30,613 (USD; Tot_Drug_Cst)2018 Drug cost: $28,323 (USD; Tot_Drug_Cst)2019 Drug cost: $37,628 (USD; Tot_Drug_Cst)2020 Drug cost: $44,248 (USD; Tot_Drug_Cst)2021 Drug cost: $48,657 (USD; Tot_Drug_Cst)2022 Drug cost: $49,845 (USD; Tot_Drug_Cst)2023 Drug cost: $74,107 (USD; Tot_Drug_Cst)2024 Drug cost: $58,248 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015127497$24,171
2016153569$31,228
2017161642$30,613
2018178698$28,323
2019189755$37,628
2020217714$44,248
2021235711$48,657
2022282872$49,845
20233111,064$74,107
20243321,207$58,248

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye230820$84
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more511631$81
92014Established patient complete exam of visual system167203$79
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4931,120$62
92134Imaging of retina9752,628$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Brimonidine TartrateBrimonidine Tartrate1346,865$10,884
LumiganBimatoprost191,019$8,442
Prednisolone AcetatePrednisolone Acetate1827,023$7,547
Alphagan PBrimonidine Tartrate18812$4,970
Ketorolac TromethamineKetorolac Tromethamine2055,931$4,197

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.15$381Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Wendewessen Amde, M.D.?

Tedicare shows public-source Medicare data for Wendewessen Amde, M.D. (NPI 1386837474), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wendewessen Amde, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Wendewessen Amde, M.D.?

Wendewessen Amde, M.D. is linked to DEKALB EYE CONSULTANTS, LLC (billing NPI 1326380510) in the available physician profile data.

Does Wendewessen Amde, M.D. have Open Payments data?

Wendewessen Amde, M.D. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.